Compare Stocks › ABBV vs NDSN

AbbVie Inc. (ABBV) vs Nordson Corporation (NDSN): Which Is the Better Buy in 2026?

As of 2026-11-01, ABBV is overvalued at $295, with a DCF intrinsic value of $172 and a margin of safety of -71%. NDSN is overvalued at $323, with an intrinsic value of $204 and a margin of safety of -58%. Of the two, NDSN has the wider margin of safety.

ABBV
AbbVie Inc.
$294.89
VS
NDSN
Nordson Corporation
$322.67

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 73.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
NDSN
  • ★Nordson Corporation has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Nordson Corporation scores 89/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • ★Free cash flow has grown at a 12.7% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
NDSN
  • ⚠Each dollar of retained earnings has produced only $0.18 of earning power — shareholders may have been better served by dividends.
  • ⚠5 insider sales with no purchases in the past 3 months — insiders are reducing their exposure.

Key Valuation Metrics

Learn more →
ABBV
NDSN
Valuation
N/A
Free Cash Flow
$613.81M
N/A
FCF Yield
3.42%
50.67
Trailing P/E
32.66
18.24
Forward P/E
24.85
Quality & Moat
29.08%
ROIC
12.68%
N/A
ROE
17.76%
73.72%
Gross Margin
55.39%
0.60
PEG Ratio
1.84
Balance Sheet Safety
N/A
Net Debt / Equity
0.52
N/A
Interest Coverage
N/A
2.03
Net Debt / EBITDA
1.78
2.35%
Dividend Yield
1.17%
ABBV: 5Ties: 1NDSN: 2
ABBVNDSN

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

NDSN

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
NDSN
$0.18
created per $1 retained over 3 years
Value Destroyer
Σ Retained
$948.4M
Δ Market Cap
+$175.4M
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
71.5% Overvalued
Price is 71.5% above estimated fair value
Current Price: $294.89
Fair Value: $172.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
NDSN
57.8% Overvalued
Price is 57.8% above estimated fair value
Current Price: $322.67
Fair Value: $204.48
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

NDSN

What growth rate is the market pricing in at $323?

+15.0%
Market-Implied Owner Earnings Growth
Standard FCF implies +14.1%

The market implies +15.0% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +14.1%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
NDSN
89/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
NDSN
-2.65
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
No. of Institutional Holders5,303
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
NDSN
Insiders 0.3%Institutions 78.7%Retail & Other 21.0%
No. of Institutional Holders1,091
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
NDSN
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
1
Sells (3M)
4
Sells (12M)
Total value (12M): $18.92M
DONOGHOE NICHOLAS
Officer
$8.18M
@ $250.00 · 2026-08-14
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
NDSN
5
Sells (3M)
13
Sells (12M)
Total value (12M): $25.68M
MORRIS MILTON MAYO
Director
$83,436
@ $327.20 · 2026-10-14
RUTLEDGE JOSEPH M.
Officer
$211,616
@ $309.38 · 2026-09-15
MORRIS MILTON MAYO
Director
$49,394
@ $316.63 · 2026-09-02
MCDONOUGH JENNIFER L
General Counsel
$87,360
@ $336.00 · 2026-08-27
HOPGOOD DANIEL ROY
Chief Financial Officer
$444,271
@ $334.29 · 2026-08-26
SUBRAMANIAN SRINIVAS
Officer
$868,000
@ $280.00 · 2026-04-17
MORRIS MILTON MAYO
Director
$67,098
@ $273.87 · 2026-04-15
HALL JUSTIN E
Officer
$197,487
@ $275.82 · 2026-04-08
NAGARAJAN SUNDARAM
Chief Executive Officer
$12.26M
@ $293.26 · 2026-02-24
KELLEY JOSEPH P
Officer
$2.56M
@ $293.04 · 2026-02-24
KELLEY JOSEPH P
Officer
$6.67M
@ $289.31 · 2026-02-23
DEVRIES JAMES E.
Officer
$2.13M
@ $233.60 · 2025-11-10
MORRIS MILTON MAYO
Director
$61,215
@ $231.00 · 2025-11-03
KELLEY JOSEPH P
Officer
$528,000
@ $240.00 · 2025-10-21
KELLEY JOSEPH P
Officer
$534,497
@ $232.39 · 2025-10-16
LOVASS STEPHEN P
Officer
$268,620
@ $206.79 · 2025-01-07
MCDONOUGH JENNIFER L
General Counsel
$68,056
@ $260.75 · 2024-12-02
LOVASS STEPHEN P
Officer
$82,658
@ $260.75 · 2024-12-02
MCDONOUGH JENNIFER L
General Counsel
$22,791
@ $261.97 · 2024-11-25
LOVASS STEPHEN P
Officer
$34,842
@ $261.97 · 2024-11-25
MCDONOUGH JENNIFER L
General Counsel
$59,011
@ $262.27 · 2024-11-11
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(72/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
NDSN
FearGreed
😏Greed(61/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
NDSN
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (61)
View ABBV Full AnalysisView NDSN Full Analysis

Frequently Asked Questions: ABBV vs NDSN

Is AbbVie Inc. or Nordson Corporation more undervalued in 2026?▼

Based on our discounted cash flow model, NDSN trades at a -57.8% margin of safety (intrinsic value $204 vs. price $323), compared to ABBV's -71.5% margin of safety (intrinsic $172 vs. $295).

Which stock has a wider economic moat, AbbVie Inc. or Nordson Corporation?▼

NDSN scores 89/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?▼

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. NDSN scores 4.9 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or Nordson Corporation?▼

ABBV earns 29.1% ROIC versus NDSN's 12.7%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Nordson Corporation's?▼

NDSN's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). NDSN has raised its dividend for 3 consecutive years.

ABBV vs NDSN: Which Is the Better Buy in 2026? | SafetyMargin.io